Næste

Automatisk afspilning

Chemotherapy Toxicity Considerations in Soft Tissue Sarcoma

0 Visninger • 07/18/23
Del
Indlejre
administrator
administrator
Abonnenter
0

The panelists, Brian Van Tine, MD, PhD; Robin Jones, MD, MRCP; Andrew Wagner, MD, PhD; Lor Randall, MD, FACS; Shreyaskumar Patel, MD; and Jonathan Trent, MD, PhD; discuss the factors they consider when balancing the risks and benefits of chemotherapy treatment in soft tissue sarcoma.

Vis mere
0 Kommentarer sort Sorter efter
Facebook kommentarer

Næste

Automatisk afspilning